Plus Therapeutics Inc (PSTV) — Cash Flow Quality Index
Latest as of June 2025:
-1.13x
Plus Therapeutics Inc (PSTV) has a Cash Flow Quality Index of -1.13x as of June 2025. Operating cash flow of $-5.80 Million is below net income of $5.15 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore PSTV total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-1.13x
Operating CF / Net Income
Operating Cash Flow
$-5.80 Million
USD
Net Income
$5.15 Million
USD
Data as of
Jun 2025
Most recent filing
Annual Cash Flow Quality Index for Plus Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Plus Therapeutics Inc. For live market cap and the full company financial profile, see market value of Plus Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.